New antibody drug allowed Covid-19 patients to breathe on their own: Lenzilumab – Health News

An antibody drug developed by the US pharmaceutical company Humanigen allowed severe Covid-19 patients hospitalized to breathe on their own. The researchers reported that patients who took the drug Lenzilumab had an almost 60 percent higher chance of surviving without the need for mechanical ventilation. 540 PEOPLE WERE INCLUDED IN THE STUDY However, it was noted that the 540 patients in the randomized trial were currently receiving various standard therapies, and half were given intravenous…

"New antibody drug allowed Covid-19 patients to breathe on their own: Lenzilumab – Health News"